Global Metabolic Disorder Therapeutics Market Size & Growth Analysis Report, 2020-2026

 The global metabolic disorder therapeutics market is estimated to grow at a CAGR of 7.8% during the forecast period. An increasing number of clinical trials have been witnessed over the years owing to the rising prevalence of metabolic disorders and increasing demand for more effective treatment. For instance, in May 2020, POXEL SA, a biopharmaceutical company focused to develop innovative treatments for metabolic disorders, such as non-alcoholic steatohepatitis (NASH) and type 2 diabetes declared new preclinical results for PXL770. It is a direct adenosine monophosphate-activated protein kinase(AMPK) activator, was assessed in a rodent NASH model along with other major agents in development, such as a thyroid receptor ? agonist (MGL-3196), an FXR agonist (obeticholic acid), and a GLP-1 receptor agonist (semaglutide). 

To Request a Sample of our Report on Global Metabolic Disorder Therapeutics Market:  https://www.omrglobal.com/request-sample/metabolic-disorder-therapeutics-market

The outcomes feature PXL770 as a potential new NASH therapy that may develop complementary advantages while combined with other agents with different action mechanisms. Further, in September 2020, Kaleido Biosciences, Inc. declared that it has evaluated Microbiome Metabolic Therapy (MMT) candidate KB295 in the first patient suffering from mild-to-moderate ulcerative colitis. Such kinds of clinical studies are offering an opportunity for new launches of innovative therapies for metabolic disorders, which in turn, will further accelerate the market growth.

Scope of the Global Metabolic Disorder Therapeutics Market

Market Coverage

·        Market number available for 2019-2026

·        Base year- 2019

·        Forecast period- 2020-2026

·        Segment Covered- By Therapy and Disease

·        Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World

·        Competitive Landscape- AbbVie, Inc., Novo Nordisk A/S, Sanofi SA, Boehringer Ingelheim GmbH, and AstraZeneca plc

Recent Strategic Initiatives in the Global Metabolic Disorder Therapeutics Market

·        In March 2020, AstraZeneca plc declared the collaboration with Silence Therapeutics for discovery, development, and commercialization of small interfering RNA (siRNA) therapeutics to treat CVD, respiratory, renal, and metabolic disorders. This multi-target partnership will use the established small interfering RNA (siRNA) platform of Silence to detect and progress liver-based targets and develop new delivery methods to target other tissues including the heart, kidney, and lung. 

·        In March 2020, Eli Lilly and Co. declared the global licensing and research partnership with Sitryx, a biopharmaceutical company engaged in the development of therapeutics in immuno-inflammation and immuno-oncology. Under the partnership, the companies will study up to four new preclinical targets that are identified by Sitryx that could result in potential new medicines for autoimmune diseases. Lilly will make a $10 million equity investment in Sitryx and Sitryx will get an upfront payment of $50 million.

Key questions addressed by the report

·        What is the market growth rate?

·        Which segment/region dominates the market in the base year?

·        Which segment/region will project the fastest growth in the market?

·        How COVID-19 impacted the market?

o             Recovery Timeline

o             Deviation from the pre-COVID forecast

o             Most affected region/segment

·        Who is the leader in the market?

·        How players are addressing challenges to sustain growth?

·        Where is the investment opportunity?

·         

(Get 15% Discount on Buying this Report)

A full Report of Global Metabolic Disorder Therapeutics Market is Available at:  https://www.omrglobal.com/industry-reports/metabolic-disorder-therapeutics-market

 Global Metabolic Disorder Therapeutics Market-Segmentation

 By Therapy

·        Drug Therapy

·        Gene Therapy

·        Cellular Transplantation

·        Enzyme Replacement Therapy

·        Others

By Disease

·        Obesity

·        Diabetes

·        Lysosomal Storage Disease

·        Hypercholesterolemia

·        Others

Global Metabolic Disorder Therapeutics Market– Segment by Region

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of The World

·                  Latin America 

·                  Middle East & Africa

Company Profiles

·        AbbVie, Inc.

·        Actelion Pharmaceuticals, Ltd.

·        Agios Pharmaceuticals, Inc.

·        Alexion Pharmaceuticals, Inc.

·        Amgen, Inc.

·        AstraZeneca plc

·        Biocon, Ltd.

·        BioMarin Pharmaceutical, Inc.

·        Boehringer Ingelheim GmbH

·        Bristol-Myers Squibb Co.

·        Cipla, Inc.

·        CymaBay Therapeutics, Inc.

·        Dracen Pharmaceuticals, Inc.

·        Eli Lilly and Co.

·        Intra-Cellular Therapies, Inc.

·        Merck KGaA

·        Novo Nordisk A/S

·        Orchard Therapeutics plc

·        Pfizer, Inc.

·        Sanofi S.A.

·        Shire Pharmaceuticals Group plc

·        Sigilon Therapeutics, Inc.

·        Silence Therapeutics

Reasons for Buying from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/metabolic-disorder-therapeutics-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more